Price:
Rs. 12,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: M8513
Frequently Asked Questions (FAQ's):
What does this test include?
This test evaluates abnormal immunophenotypic patterns of blood cells to identify changes linked to Myelodysplastic Syndromes.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced multiparameter flow cytometry technology to study cell surface markers and detect atypical hematopoietic cells.
Who should take this test?
Individuals with unexplained anemia, recurrent infections, easy bruising, or suspected bone marrow disorders may require this test.
What sample type is required?
EDTA whole blood is required for flow cytometry analysis.
Is fasting needed for this test?
No, fasting is not required.
How can Metropolis Healthcare’s results help doctors?
Accurate profiling assists clinicians in diagnosing MDS, determining severity, and planning further investigations or treatment.
Can this test detect progression toward leukemia?
Yes, flow cytometry helps identify changes that may indicate risk of progression to acute myeloid leukemia (AML).
Does Metropolis Healthcare offer additional supportive tests?
Yes, tests such as bone marrow evaluation, cytogenetics, and molecular panels are available to complement MDS diagnosis